•New Approved Drugs: |
With all source categories (Figure 1) |
•New Approved Drugs: |
By source/year (Figure 2) |
•Sources of all NCEs: |
Where four or more drugs were approved per medical indication (Table 1), with listings of diseases with < 3 approved drugs |
•Sources of Small-Molecule NCEs: |
All subdivisions (Figure 3) |
•Sources of Small-Molecule NCEs: |
By source/year (Figure 4) |
•Percent N/NB/ND: |
By year (Figure 5) |
•Total Small Molecules: |
By year (Figure 6) |
•Antibacterial Drugs: |
Generic and trade names, year, reference and source (Table 2) |
•Antifungal Drugs |
Generic and trade names, year, reference and source (Table 3) |
•Antiviral Drugs |
Generic and trade names, year, reference and source (Table 4) |
•Antiparasitic Drugs |
Generic and trade names, year, reference and source (Table 5) |
•Antiinfective Drugs |
All molecules, source and numbers (Table 6) |
•Antiinfective Drugs |
Small molecules, source and numbers (Table 7) |
•Anticancer Drugs |
Generic and trade names, year, reference and source (Table 8; Figure 7) |
•All Anticancer Drugs (very late 1930s-12/2010) |
Generic and trade names, year, reference and source Table 9; Figures 8, 9) |
•Antidiabetic Drugs |
Generic and trade names, year, reference and source (Table 10) |